4.0 Article

Fatal leukemia in interleukin-15 transgenic mice

期刊

BLOOD CELLS MOLECULES AND DISEASES
卷 27, 期 1, 页码 223-230

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1006/bcmd.2001.0379

关键词

-

资金

  1. NATIONAL CANCER INSTITUTE [R37CA068458, T32CA009498, R01CA065670, R01CA068458, P30CA016058] Funding Source: NIH RePORTER
  2. NCI NIH HHS [T32 CA-09498, CA-68458, P30CA-16058, CA-65670] Funding Source: Medline

向作者/读者索取更多资源

The role of inflammation in the early genesis of certain malignancies has recently been appreciated. Interleukin (IL)-15, a proinflammatory cytokine and growth factor, is required for lymphocyte homeostasis. Intriguingly, the expression of IL-15 protein is tightly controlled by multiple posttranscriptional mechanisms, suggesting that inappropriate expression of IL-15 may be detrimental to the host. We recently engineered a transgenic mouse in which the normal posttranscriptional control of IL-15 is eliminated, thereby overexpressing the murine IL-15 protein. IL-15 transgenic mice have early expansions in NK and CD8(+) T lymphocytes and later develop fatal lymphocytic leukemia with a T-NK phenotype. This article recapitulates the phenotype of these IL-15 transgenic mice and discusses the utility of this model as a tool to further our understanding of leukemogenesis. (C) 2001 Academic Press.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据